Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
#What Are The Current (2025) And Forecast (2029) Sizes Of The Macular Degeneration Treatment Market?
The macular degeneration treatment market has experienced rapid expansion recently. Forecasts indicate its expansion from $11.05 billion in 2024 to $12.38 billion in 2025, driven by a compound annual growth rate (CAGR) of 12.0%. This historical growth is largely attributable to factors including an aging population, lifestyle changes, limited treatment options, rising awareness, and the development of healthcare infrastructure.
The macular degeneration treatment market size is anticipated to experience significant expansion over the next few years, reaching $18.87 billion by 2029 with a compound annual growth rate (CAGR) of 11.1%. This growth during the forecast period is propelled by factors such as advancements in research, increased healthcare expenditure, rising incidence rates, the adoption of personalized medicine approaches, and global initiatives for vision health. Prominent trends in the same period encompass an emphasis on neuroprotection and regeneration therapies, the broadening of telemedicine and remote monitoring, continued application of personalized medicine strategies, the investigation of stem cell therapies, and patient-focused programs for awareness and education.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5799&type=smp
What Are The Top Growth Drivers Impacting The Macular Degeneration Treatment Market Outlook?
The escalating prevalence of retinal disorders is anticipated to stimulate the expansion of the macular degeneration treatment market. These conditions damage vital retinal tissue and interfere with how individuals process visual information, resulting in impaired or absent vision. For example, the American Academy of Ophthalmology projects that by 2050, around 7.32 million people in the United States will suffer from primary open-angle glaucoma, a broad category encompassing various eye disorders, with the highest proportions observed in populations aged 70 to 79 years (32%), women (50%), and Hispanics (50%). The most significant demographic within this group is Hispanic men. Thus, the rising burden of retinal disorders is propelling the growth of the macular degeneration treatment market.
What Are The Key Segments In The Macular Degeneration Treatment Market?
The macular degeneration treatmentmarket covered in this report is segmented –
1) By Stage of Disease: Early-Stage AMD; Intermediate AMD; Late-Stage AMD
2) By End User: Ambulatory Surgical Centers; Ophthalmic Clinics; Hospitals
3) By Route of Administration: Oral; Injectable; Other Route of Administration
4) By Types: Wet Macular Degeneration, Dry Macular Degeneration
Subsegments:
1) By Early-Stage AMD: Nutritional Supplements; Lifestyle Modification Treatments
2) By Intermediate AMD: Anti-VEGF Injections; Photodynamic Therapy
3) By Late-Stage AMD: Surgical Treatments; Advanced Anti-VEGF Therapies; Gene Therapy Options
How Are Emerging Market Trends Shaping The Macular Degeneration Treatment Industry Landscape?
Leading firms within the macular degeneration treatment market are prioritizing the creation of biosimilars aimed at managing age-related macular degeneration (AMD), thereby enhancing access to successful treatments. These biosimilars are biological medical products that exhibit strong resemblance to an existing approved reference product, displaying no significant clinical distinctions regarding safety, purity, or potency. An example of this trend occurred in May 2024, when Biocon Biologics Ltd, based in India, and Samsung Bioepis Co. Ltd, a South Korea-based enterprise, secured FDA Approvals for their new biosimilars, Yesafili and Opuviz. Both of these biosimilars work by inhibiting vascular endothelial growth factor (VEGF), a protein known to cause atypical blood vessel proliferation in the eye. This mechanism is crucial for preventing the loss of vision linked to conditions such as AMD and diabetic retinopathy. The FDA’s rigorous approval methodology incorporated comparative research, which demonstrated that Yesafili and Opuviz possess equivalent efficacy and safety profiles when benchmarked against Eylea. These assessments thoroughly evaluated the pharmacokinetics and immunogenicity of the biosimilars.
Which Leading Players Are Enhancing Their Macular Degeneration Treatment Market Presence Worldwide?
Major companies operating in the macular degeneration treatment market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Allergan Inc., Bayer AG, Novartis AG, GlaxoSmithKline plc, Panoptica, Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Santen Pharmaceuticals, Aerie Pharmaceuticals Inc., BioXcel Therapeutics Inc., Regenxbio Inc., Spark Therapeutics Inc., Alimera Sciences Inc., Applied Genetic Technologies Corp (AGTC), Cell Medica Ltd., Ophthotech Corporation, Adverum Biotechnologies Inc., Neurotech Pharmaceuticals Inc., 4D Molecular Therapeutics Inc., GenSight Biologics Inc.
Download The Full Report For Exclusive Market Findings:
Which Regional Markets Are Contributing Most To The Macular Degeneration Treatment Industry Expansion?
North America was the largest region in the macular degeneration treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the macular degeneration treatment Market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Macular Degeneration Treatment Market Report:
https://www.thebusinessresearchcompany.com/customise?id=5799&type=smp
Browse Through More Reports Similar to the Global Macular Degeneration Treatment Market 2025, By The Business Research Company
Gastrointestinal Bleeding Treatment Devices Global Market Report 2025
Gastrointestinal Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/gastrointestinal-devices-global-market-report
Medical Equipment Maintenance Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/medical-equipment-maintenance-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model